The Lancet: World population gains more than 6 years of life expectancy since 1990

December 17, 2014

Global life expectancy increased by 5.8 years in men and 6.6 years in women between 1990 and 2013, according to a major new analysis from the Global Burden of Disease Study 2013 (GBD 2013).

However, some causes of death ran counter to these trends and have seen increased rates of death [1] since 1990, including: liver cancer caused by hepatitis C (up by 125%), atrial fibrillation and flutter (serious disorders of heart rhythm; up by 100%), drug use disorders (up by 63%), chronic kidney disease (up by 37%), sickle cell disorders (up by 29%), diabetes (up by 9%), and pancreatic cancer (up by 7%).

In high-income regions, falling death rates from most cancers (down by 15%) and cardiovascular diseases (down by 22%) have increased life expectancy, while rapidly declining death rates for diarrhoea, lower respiratory tract infections, and neonatal disorders have helped extend life expectancy in low-income countries (see figure 7 page 14, and table 2 pages 15-23).

While life expectancies are increasing throughout the world, there is one notable exception: southern sub-Saharan Africa, where deaths from HIV/AIDS have erased over 5 years of life expectancy (see figure 7 page 14).

"The progress we are seeing against a variety of illnesses and injuries is good, even remarkable, but we can and must do even better", says lead author Dr Christopher Murray, Professor of Global Health at the University of Washington in the USA. "The huge increase in collective action and funding given to the major infectious diseases such as diarrhoea, measles, tuberculosis, HIV/AIDS, and malaria has had a real impact. However, this study shows that some major chronic diseases have been largely neglected but are rising in importance, particularly drug disorders, liver cirrhosis, diabetes, and chronic kidney disease."*

The findings come from GBD 2013, the most comprehensive and up-to-date estimates of the number of yearly deaths due to 240 different causes in 188 countries over 23 years (1990 to 2013). The amount of data in GBD 2013 have been significantly expanded from GBD 2010 to include both more data from certain countries (China, Russia, Turkey), and additional data on conditions such as cancers and HIV/AIDS.

Key findings include:For more detailed findings for each country and all regions see figure 12 pages 32-35, plus the main Appendix for the study.

Writing in a linked Comment, Igor Rudan and Kit Yee Chan from the Centre for Population Health Sciences and Global Health Academy at the University of Edinburgh Medical School in the UK call for continuing competition between research groups to improve science. They write that, "Estimates of the causes of the global burden of disease, disability, and death are important because they guide investment decisions that, in turn, save lives across the world. Historically, the responsibility for those estimates rested largely with WHO and its academic partners. Although WHO's team of experts have been doing fine technical work for many years, its monopoly in this field had removed incentives to invest more time and resources in continuous improvement. The emergence of the Institute for Health Metrics and Evaluation, generously supported by the Bill & Melinda Gates Foundation, has changed the science of global health metrics in a similar way to Celera Genomics' competition with the Human Genome Project...the competition between WHO and the GBD has benefited the entire global health community, leading to converging estimates of the global causes of death that everyone can trust."
-end-
NOTES TO EDITORS:

This study was funded by the Bill & Melinda Gates Foundation

*Quote direct from author and cannot be found in text of Article.

[1] Death rates age standardised per 100 000 population

[2] Uncertainty around these estimates is large because several different estimates exist. These estimates are of the direct deaths resulting from armed conflicts and do not account for the full effects of associated factors such as the breakdown of health systems or critical infrastructure.

The Lancet

Related Chronic Kidney Disease Articles from Brightsurf:

How to ensure patients manage their chronic kidney disease
A Singapore study finds patients with chronic kidney disease need tailored nutrition guidance, as well as better communication with doctors and family support, to empower them to manage their condition.

Children with chronic kidney disease have outsized health burden
Chronically ill children with kidney disease may spend more time in the hospital, incur larger health care costs and have a higher risk of death compared to pediatric patients hospitalized for other chronic conditions, a new study suggests.

Your neighborhood may raise your risk of chronic kidney disease
A neighborhood's overall socioeconomic status, including income and education-level, may influence its residents' risk of chronic kidney disease, according to a study recently published in SSM Population Health by researchers from Drexel University's Dornsife School of Public Health.

These lifestyle choices can reduce the risk of chronic kidney disease
Active lifestyle choices such as eating vegetables, exercising and quitting smoking can reduce the risk of chronic kidney disease, a new study led by researchers at Karolinska Institutet in Sweden and Griffith University in Australia, reports.

SGLT2 inhibitors can slow progression of chronic kidney disease
The CREDENCE trial [3] provided evidence that the SGLT2 inhibitor Canagliflozin slows the progression of CKD in individuals with type 2 diabetes (T2D) and CKD with albuminuria.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.

Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).

New tool predicts five-year risk of chronic kidney disease
A new risk calculator tool that uses a mix of variables including age, hypertension, and diabetes status can be used to predict accurately whether someone is likely to develop chronic kidney disease within five years.

Gap in care found for patients with chronic kidney disease: study
Millions of Canadians living with chronic kidney disease (CKD) may be going without critical testing from their primary care practitioners that would give them a good idea of the severity of the disease so they could intervene earlier with more appropriate care, according to a new study.

Read More: Chronic Kidney Disease News and Chronic Kidney Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.